Cargando...

UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression

The success of proteasome inhibition in multiple myeloma highlights the critical role for the ubiquitin-proteasome system (UPS) in this disease. However, there has been little progress in finding more specific targets within the UPS involved in myeloma pathogenesis. We previously found the ubiquitin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Hussain, Sajjad, Bedekovics, Tibor, Chesi, Marta, Bergsagel, P. Leif, Galardy, Paul J.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747363/
https://ncbi.nlm.nih.gov/pubmed/26513019
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!